←Back to Expert Scholars
Translational Medicine / 转化医学Triple Negative Breast Cancer, Immunotherapy
Rita Nanda
MD
🏢University of Chicago Medicine🌐USA
Director, Breast Oncology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Rita Nanda has led triple negative breast cancer immunotherapy trials including contributions to the I-SPY 2 platform. Her work informs response-directed de-escalation and escalation decisions in neoadjuvant therapy. She directs breast oncology at the University of Chicago.
Share:
🧪Research Fields 研究领域
triple negative breast cancer
immunotherapy
neoadjuvant therapy
I-SPY trials
de-escalation
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Rita Nanda 的研究动态
Follow Rita Nanda's research updates
留下邮箱，当我们发布与 Rita Nanda（University of Chicago Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment